Relapsed or Refractory Hodgkin's Lymphoma
2 clinical trials · Condition
◉ Watch Relapsed or Refractory Hodgkin's Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients (NCT05300282) | Fondazione Italiana Linfomi - ETS | 2023-02-27 |
| Patient-reported and Clinical Outcomes in Adults With Relapsed or Refractory Hodgkin's Lymphoma Receiving Brentuximab Vedotin (NCT03440788) | Multinational Center for Quality of Life Research, Russia | 2018-04-02 |
Track Relapsed or Refractory Hodgkin's Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.